Lv1
30 积分 2022-06-27 加入
Early-Onset Gastrointestinal Cancers
3天前
已完结
Early-Onset Gastrointestinal Cancers
3天前
已完结
Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy
6个月前
已完结
[Advances in Pseudoprogression of Immune Checkpoint Inhibitors
in Non-small Cell Lung Cancer]
6个月前
已完结
Lung cancer treatment: 20 years of progress
7个月前
已完结
Kaplan-Meier Survival Analysis: Practical Insights for Clinicians
8个月前
已完结
Colorectal Cancer with BRAF V600E Mutation: Trends in Immune Checkpoint Inhibitor Treatment
8个月前
已完结
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
10个月前
已完结
Protein Kinases – High Yield Targets for Cancer and Dementia Drug Discovery
10个月前
已完结
Evolutionary trajectories of small cell lung cancer under therapy
10个月前
已完结
皖公网安备34019202002308
